CWA
TEVA icon

Carolina Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Carolina Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,508
Closed -$64K – 275
2022
Q2 		$64K Buy
8,508
+560
+7% +$4.88K 0.04% 109
2022
Q1 		$75K Buy
7,948
+405
+5% +$3.38K 0.05% 106
2021
Q4 		$60K Buy
7,543
+174
+2% +$1.57K 0.03% 131
2021
Q3 		$72K Sell
7,369
-72
-1% -$674 0.05% 115
2021
Q2 		$74K Buy
7,441
+1,161
+18% +$12.3K 0.05% 121
2021
Q1 		$72K Buy
6,280
+6,233
+13,262% +$71.5K 0.05% 110
2020
Q4 		$0 Hold
47
– – ﹤0.01% 256
2020
Q3 		$0 Hold
47
– – ﹤0.01% 228
2020
Q2 		$1K Hold
47
– – ﹤0.01% 163
2020
Q1 		$0 Hold
47
– – ﹤0.01% 203
2019
Q4 		$0 Buy
+47
New +$420 ﹤0.01% 185

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Carolina Wealth Advisors's TEVA Position: Q3 2022 in Review

Carolina Wealth Advisors sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 8,508 shares — an estimated $64K sold.

Carolina Wealth Advisors first reported a position in TEVA in Q4 2019 and held it in 11 quarters. The position peaked at $75K in Q1 2022. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

  • Carolina Wealth Advisors reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Carolina Wealth Advisors sold 8,508 Teva Pharmaceuticals shares in Q3 2022, an estimated $64K.
  • Carolina Wealth Advisors first reported a position in Teva Pharmaceuticals in Q4 2019 and held it in 11 quarters.
  • Carolina Wealth Advisors's Teva Pharmaceuticals position peaked at $75K in Q1 2022.
  • 430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Carolina Wealth Advisors's 13F filing for Q3 2022, filed 14 Oct 2022.